GARDNER -- Dr. David M. Harlan, a leading figure in diabetes care and clinical research, will be the featured presenter at the annual Heywood Hospital Diabetes Education Fair to be held at Mount Wachusett Community College on Sept.

This one's for Carol, I know he is reading.

"Two studies reveal that smokers may have a significantly lower risk of developing lung cancer and colorectal cancer with the drug metformin, which is commonly prescribed for diabetes type 2 treatment, the medical journal Cancer Prevention Research informs. Metformin, originally sold as Glucophage, is the first-line drug of choice for diabetes type 2 patients, especially those who are obese or ..."

WWW.YOUTUBE.COM writes:

I saw this posted Thursday on WWW.OMAHA.COM.

"A growing body of evidence suggests that the widely used diabetes drug metformin can reduce the risk of cancer, researchers said Wednesday."

This one is for my brother Sheila:

"CHICAGO - THE common diabetes drug metformin may hold promise as a way to keep smokers from developing lung cancer, US researchers said on Wednesday. They said metformin prevented lung tumour growth in mice exposed to a cancer-causing agent found in tobacco smoke, and because it is already widely used in people, it may be worth further study."

This one's for Ricky, I know she is reading.

"The common diabetes drug metformin may hold promise as a way to keep smokers from developing lung cancer, U.S. researchers said on Wednesday."

Judith wrote:

Did anyone else see this article?

"Metformin reduced the development of lung tumors in mice by more than 70%. Clinical trials on humans for lung, breast and prostate cancer are being organized. A growing body of evidence suggests that the widely used diabetes drug metformin can reduce the risk of cancer, researchers said Wednesday."